Screener
Eastman Chemical EMN Income Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| -$56M-3.7% | -$55M-3.8% | -$52M-6.1% | -$52M0.0% | -$54M-10.2% | ||
| $2.39B+8.3% | $2.51B+9.9% | $2.18B-4.9% | $1.97B-12.1% | $2.2B-10.6% | ||
| $1.85B+4.7% | $1.95B+9.7% | $1.75B+1.3% | $1.64B-3.3% | $1.77B-4.8% | ||
| $532M+22.9% | $560M+10.7% | $431M-24.0% | $338M-39.0% | $433M-28.4% | ||
| 22.3%+2.6pp | 22.3%+0.2pp | 19.8%-5.0pp | 17.1%-7.5pp | 19.7%-4.9pp | ||
| $63M0.0% | $65M-3.0% | $60M-10.4% | $58M-12.1% | $63M-3.1% | ||
| $171M+6.9% | $185M+17.8% | $178M-2.2% | $159M-12.6% | $160M-12.6% | ||
| -$10M-233% | -$14M+71.4% | -$13M-62.5% | -$24M-380% | -$3M0.0% | ||
| $249M+85.8% | $256M+51.5% | $136M-46.2% | $12M-96.0% | $134M-52.1% | ||
| -$4M-105% | $72M+148% | $29M-58.6% | —— | $87M-12.1% | ||
| $252M+436% | $183M+30.7% | $107M-41.2% | $105M-68.2% | $47M-73.9% | ||
| 10.6%+8.4pp | 7.3%+1.2pp | 4.9%-3.0pp | 5.3%-9.4pp | 2.1%-5.2pp | ||
| $2.19+447% | $1.59+32.5% | $0.93-40.8% | $0.92-67.3% | $0.40-73.9% | ||
| $383M+45.6% | $388M+31.1% | $267M-29.6% | $143M-66.4% | $263M-35.4% | ||
| 16.1%+4.1pp | 15.4%+2.5pp | 12.3%-4.3pp | 7.2%-11.7pp | 11.9%-4.6pp | ||
| $249M+85.8% | $256M+51.5% | $136M-46.2% | $12M-96.0% | $134M-52.1% |
FAQ
- What is Eastman Chemical's revenue?
- Eastman Chemical (EMN) generated $9.0B in revenue over the trailing twelve months, up 0.3% year over year.
- Is Eastman Chemical profitable?
- Eastman Chemical reported $647.0M in net income over the trailing twelve months, a 7.2% net margin.
- What are Eastman Chemical's profit margins?
- Gross margin is 20.6% and operating margin is 16.0%, with a 7.2% net margin.
- What is Eastman Chemical's earnings per share?
- Eastman Chemical's diluted EPS over the trailing twelve months is $5.63.
- Where does Eastman Chemical's income statement data come from?
- Every line is extracted from Eastman Chemical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
